Treatment of Primary Liver Cancer by Orthotopic Liver Transplantation

严律南,李波,卢实春,文天夫,曾勇,赵继春,马玉奎,王文涛,杨家印,李志辉
DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2005.08.005
2005-01-01
Abstract:Objective To determine the clinical indications and results in patients with primary liver cancer (PLC) for orthotopic liver transplantation (OLT). Methods The clinical data of 170 patients receiving OLT from February 1999 to April 2004 in our hospital were retrospectively analyzed. Amongst the 170 patients, 62 were with PLC. The clinical staging, surgical approach and long-term survival rate were analyzed in the 62 patients to explore the reasons for success and failure. Results Of the 62 patients, 4 died during hospitalization (mortality=6.45%). The follow-up study for 1-39 months showed that the 1-, 2- and 3-year recurrence rates were 29.31%, 41.38% and 58.06%, and the 1-, 2- and 3-year survival rates 87.45%, 65.59% and 42.06%, respectively. Further study revealed that all the 6 patients with tumor diameter less than 5 cm were alive but all the 7 patients (except 1) with portal vein cancer thrombosis had recurrence or died. Conclusions The PLC without portal vein cancer thrombosis can be the indication of OLT in our country. Perioperative prevention method for recurrence of liver cancer should be explored for raising survival rate in the patients with PLC after OLT.
What problem does this paper attempt to address?